Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Johnandrose22on Dec 12, 2020 1:39pm

224 Views

Post# 32093641

RE:RE:AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease P

From what I understand, Alexion has 5 approved medicines in market...over 20 clinical trials at different stages of development...25 offices worldwide and 3000 employees....all focused on the treatment of rare diseases. If Theralase is able to successfully reach (or get close to) its clinical goals for the diseases it is currently exploring (which are not rare) than, perhaps in time, the Alexion buyout could be a foreshadowing of their own.

PS....With no “mistakes”.

John

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment